RERE(RERE)
RERE
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $26.97B | $32.98B | $40.33B |
| Low | $26.24B | $32.08B | $39.38B |
| High | $27.46B | $33.57B | $41.11B |
| EBITDA Avg | $5.46B | $6.67B | $8.16B |
| Low | $5.31B | $6.49B | $7.97B |
| High | $5.56B | $6.79B | $8.32B |
| EBIT Avg | $6.28B | $7.68B | $9.39B |
| Low | $6.11B | $7.47B | $9.17B |
| High | $6.39B | $7.82B | $9.57B |
| Net Income Avg | $1.20B | $1.65B | $2.36B |
| Low | $1.16B | $1.60B | $2.21B |
| High | $1.23B | $1.69B | $2.51B |
| EPS Avg | $3.30 | $4.54 | $6.47 |
| Low | $3.18 | $4.38 | $6.05 |
| High | $3.38 | $4.64 | $6.89 |
| Analysts (Rev / EPS) | 3 / 3 | 4 / 3 | 4 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $6.55B | $7.67B | $7.00B | $7.47B | $7.99B | $8.87B |
| Low | $6.33B | $7.31B | $6.77B | $7.22B | $7.72B | $8.58B |
| High | $6.77B | $8.03B | $7.24B | $7.72B | $8.26B | $9.17B |
| EBITDA Avg | $1.33B | $1.55B | $1.42B | $1.51B | $1.62B | $1.80B |
| Low | $1.28B | $1.48B | $1.37B | $1.46B | $1.56B | $1.74B |
| High | $1.37B | $1.63B | $1.47B | $1.56B | $1.67B | $1.86B |
| EBIT Avg | $1.53B | $1.79B | $1.63B | $1.74B | $1.86B | $2.07B |
| Low | $1.47B | $1.70B | $1.58B | $1.68B | $1.80B | $2.00B |
| High | $1.58B | $1.87B | $1.69B | $1.80B | $1.92B | $2.14B |
| Net Income Avg | $339M | $396M | $333M | $384M | $487M | $574M |
| Low | $324M | $359M | $318M | $367M | $465M | $549M |
| High | $353M | $432M | $347M | $401M | $508M | $599M |
| EPS Avg | $0.93 | $1.09 | $0.92 | $1.06 | $1.34 | $1.58 |
| Low | $0.89 | $0.99 | $0.88 | $1.01 | $1.28 | $1.51 |
| High | $0.97 | $1.19 | $0.96 | $1.10 | $1.40 | $1.65 |
| Analysts (Rev / EPS) | 1 / 1 | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |